Oncolytic viruses—immunotherapeutics on the rise-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncolytic viruses—immunotherapeutics on the rise

Published:2016-08-04 Issue:9 Volume:94 Page:979-991
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Keller Brian A.,Bell John C.

Funder

Terry Fox Foundation (CA)

Ontario Institute for Cancer Research (CA)

Canadian Cancer Society Research Institute

Canadian Institutes of Health Research (CA)

Ottawa Hospital Foundation

The Ottawa Regional Cancer Foundation

Biotherapeutics for Cancer Treatment

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-016-1453-9.pdf

Reference97 articles.

1. Couzin-Frankel J (2013) Breakthrough of the year 2013. Cancer immunotherapy. Science 342:1432–1433

2. Hoos A (2016) Development of immuno-oncology drugs—from CTLA4 to PD1 to the next generations. Nat Rev Drug Discov 15:235–247

3. Sheridan C (2015) IDO inhibitors move center stage in immuno-oncology. Nat Biotechnol 33:321–322

4. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269–1274

5. Topalian SL, Sznol M, McDermott DF, Kluger HM, Carvajal RD, Sharfman WH, Brahmer JR, Lawrence DP, Atkins MB, Powderly JD et al (2014) Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol 32:1020–1030

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer;Molecular Therapy: Oncology;2024-06

2. Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAb;Cancer Letters;2024-04

3. Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers;Frontiers in Molecular Biosciences;2023-05-11

4. Intravesical oncolytic virotherapy and immunotherapy for non‐muscle‐invasive bladder cancer mouse model;BJU International;2023-04-04

5. Oncolytic Virus‐Driven Biotherapies from Bench to Bedside;Small;2023-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3